Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Peptides. 2017 Jul 15;95:25–32. doi: 10.1016/j.peptides.2017.07.007

Figure 6.

Figure 6

Effects of MXT and PACAP on the viability of U937 cells. (A) The dose-response relationship between MXT concentration and U937 cell viability after a 24-h treatment. (B) The effect of MXT and PACAP, alone and in combination, on U937 cell viability after a 24-h treatment. (C) Summary of Western blot analysis showing that the MXT-induced increase in cleaved caspase 3 is not attenuated by a 24-h co-treatment with PACAP. * p < 0.05 versus the vehicle group. # p < 0.05 MXT group versus the MXT + 1 μM PACAP group.